2020 France Hemostasis Analyzers and Reagents: Supplier Shares and Strategies, Sales Segment Forecasts, Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

Summary

This comprehensive report contains 405 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the French coagulation testing market during the next five years.

The report explores business and technological trends in the French coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrands Factor Fav/Ag, and others.

Sales and Market Share Analysis

- Sales and market shares of major instrument and reagent suppliers.

Competitive Assessments

- Extensive strategic profiles of major suppliers and emerging market entrants.

Market Segmentation Analysis

- Comprehensive market segmentation analysis, including:

   - Hospitals
   - Commercial/Private Laboratories

- Test volume forecasts  for over 40 major procedures by market segment.

Current and Emerging Products

- Review of established and emerging procedures.

- Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review

- Analysis of current and emerging technologies and their potential market applications.

- Comprehensive lists of companies developing or marketing new technologies and products by test.

Strategic Recommendations

- Product development and business expansion opportunities with significant market appeal.

- “Ideal” product models with tentative prices and operating characteristics.

- Alternative market penetration strategies for instrument and reagent suppliers.

- Potential market entry barriers and risks.


I. Introduction
II. Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests

20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrands Factor
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their
Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
4. Molecular Diagnostics
5. Microcomputers
6. Automation
7. Robotics
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
III. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument
and Reagent Suppliers Sales and Market Shares
X. Major Product Development Opportunities
XI. Design Criteria For Decentralized Testing Products

XII. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
XIII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIV. Competitive Assessments
Abbott
Accriva
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Chrono-Log
Corgenix
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPHEN BioMed
Instrumentation Laboratory/Werfen
Roche
Sekisui Diagnostics

Siemens Healthineers
Sienco
Sysmex
Thermo Fisher

List Of Tables


Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation
Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator
Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation
Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests

Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrands
Factor Tests
Executive Summary Table: France, Total Coagulation Diagnostics
Market By Market Segment and Product Category
France, Laboratories Performing Coagulation Tests By Market Segment
France, Hospital Laboratories Performing Coagulation Tests
By Bed Size
France, Commercial/Private Laboratories Performing Coagulation
Tests By Annual Test Volume
France, Hospital Laboratories Average Daily Test Volume
France, Commercial/Private Laboratories Average Daily Test Volume
France, Total Coagulation Test Volume By Market Segment
France, All Market Segments Coagulation Test Volume
France, Hospital Laboratories Coagulation Test Volume
France, Commercial/Private Laboratories Coagulation Test Volume
France, Coagulation Reagent Market By Market Segment
France, Major Suppliers of Coagulation Reagents Estimated Sales
and Market Shares

France, Coagulation Instrument Market By Market Segment
France, Major Suppliers of Coagulation Analyzers, Estimated
Instrument Sales and Market Shares
France, Total Coagulation Diagnostics Market By Product Category
France, Major Suppliers of Coagulation Diagnostic Products,
Estimated Sales and Market Shares

United States Toys Market – Growth, Demand, Trends, Opportunity, Forecasts (2020 – 2027)

The United States toys market is set to surpass US$ 56 Billion by 2027.Report Scope: The Market Size of the United States Toys Market with Six Years Forecast The United

USD 900 View Report

United States Self-Monitoring Blood Glucose (SMBG) Market Analysis 2015 – 2020 and Industry Forecast 2021 – 2027

The United States market for the self-monitoring blood glucose is anticipated to cross US$ 4.6 billion by the year-end of 2027.

USD 2500 View Report

France Hemostasis Market Database Supplier Shares Strategies

France Hemostasis Market Database--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 40 Coagulation Tests This unique report from provides information and analysis not available from any

USD 3500 View Report

France Hemostasis Analyzers Reagents Chromogenic Immunodiagnostic

2024 France Hemostasis Analyzers and Reagents--Chromogenic, Immunodiagnostic, Molecular Coagulation Test Volume and Sales Segment Forecasts for Hospitals, Commercial/Private Labs and POC Locations--2023 Competitive Shares and Growth Strategies, Latest Technologies and

USD 2500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available